Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conditional Cash Transfer Intervention to Improve Health Outcomes Among Inner-City African Americans With T2DM

NCT05559892 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT05559892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05559892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conditional Cash Transfer Intervention to Improve Health Outcomes Among Inner-City African Americans With T2DM
Lead sponsor
State University of New York at Buffalo
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 1, 2022
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes